These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 22154197)
21. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers. Darwish M; Tempero K; Kirby M; Thompson J Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093 [TBL] [Abstract][Full Text] [Related]
22. Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: a randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers. Parrillo-Campiglia S; Ercoli MC; Umpierrez O; Rodríguez P; Márquez S; Guarneri C; Estevez-Parrillo FT; Laurenz M; Estevez-Carrizo FE Clin Ther; 2009 Oct; 31(10):2224-32. PubMed ID: 19922893 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease. Smith WB; Dowell JA; Pratt RD Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688 [TBL] [Abstract][Full Text] [Related]
24. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers. Estevez-Carrizo FE; Parrillo S; Ercoli MC; Estevez-Parrillo FT Clin Ther; 2011 Jun; 33(6):738-45. PubMed ID: 21704238 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study. Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837 [TBL] [Abstract][Full Text] [Related]
26. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers. Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104 [TBL] [Abstract][Full Text] [Related]
27. Quantitative assessment of betamethasone dual-acting formulation in urine of patients with rheumatoid arthritis and ankylosing spondylitis after single-dose intramuscular administration and its application to long-term pharmacokinetic study. Kopylov AT; Novikov AA; Kaysheva AL; Vykhodets IT; Karateev DE; Zgoda VG; Lisitsa AV J Pharm Biomed Anal; 2018 Feb; 149():278-289. PubMed ID: 29128828 [TBL] [Abstract][Full Text] [Related]
28. Relative oral bioavailability of morphine and naltrexone derived from crushed morphine sulfate and naltrexone hydrochloride extended-release capsules versus intact product and versus naltrexone solution: a single-dose, randomized-sequence, open-label, three-way crossover trial in healthy volunteers. Johnson FK; Stark JG; Bieberdorf FA; Stauffer J Clin Ther; 2010 Jun; 32(6):1149-64. PubMed ID: 20637968 [TBL] [Abstract][Full Text] [Related]
29. Bioequivalence evaluation of single doses of two tramadol formulations: a randomized, open-label, two-period crossover study in healthy Brazilian volunteers. Silva Mde F; Schramm SG; Kano EK; Mori Koono EE; Porta V; dos Reis Serra CH Clin Ther; 2010 Apr; 32(4):758-65. PubMed ID: 20435245 [TBL] [Abstract][Full Text] [Related]
30. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects. Allen A; Down G; Newland A; Reynard K; Rousell V; Salmon E; Scott R Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692 [TBL] [Abstract][Full Text] [Related]
31. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study. Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895 [TBL] [Abstract][Full Text] [Related]
32. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions. Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic interactions of OBE001 and betamethasone in healthy female volunteers. Pohl O; Homery MC; Lemaux F; Patat A; Chollet A J Clin Pharm Ther; 2015 Jun; 40(3):328-32. PubMed ID: 25899007 [TBL] [Abstract][Full Text] [Related]
34. Relative bioavailability of generic and branded 250-mg and 500-mg oral chlorphenesin carbamate tablets in healthy Korean volunteers: a single-dose, randomized-sequence, open-label, two-period crossover trial. Yu JY; Song HH; Kim BG; Park HJ; Choi KS; Kwon YE Clin Ther; 2009 Nov; 31(11):2735-43. PubMed ID: 20110015 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder. Boellner SW; Pennick M; Fiske K; Lyne A; Shojaei A Pharmacotherapy; 2007 Sep; 27(9):1253-62. PubMed ID: 17723079 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers. Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG Clin Ther; 2006 May; 28(5):707-14. PubMed ID: 16861092 [TBL] [Abstract][Full Text] [Related]
37. Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers. Derks M; Kawamura H; Abt M; Meneses-Lorente G; Phelan M; Ishikawa T Clin Ther; 2011 Jun; 33(6):754-65. PubMed ID: 21704240 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects. O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of intra-articular betamethasone sodium phosphate and betamethasone acetate and endogenous hydrocortisone suppression in exercising horses. Menendez MI; Phelps MA; Bertone AL J Vet Pharmacol Ther; 2016 Feb; 39(1):22-6. PubMed ID: 25847081 [TBL] [Abstract][Full Text] [Related]
40. Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-release 10-mg tablets in patients with multiple sclerosis: a 2-week, open-label, follow-up study. Vollmer T; Blight AR; Henney HR Clin Ther; 2009 Oct; 31(10):2215-23. PubMed ID: 19922892 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]